Browse > Article
http://dx.doi.org/10.5187/jast.2020.62.6.933

Development of effective heparin extraction method from pig by-products and analysis of their bioavailability  

Lee, Da Young (Department of Animal Science and Technology, Chung-Ang University)
Lee, Seung Yun (Department of Animal Science and Technology, Chung-Ang University)
Kang, Hea Jin (Department of Animal Science and Technology, Chung-Ang University)
Park, Yeonhwa (Department of Food Science, University of Massachusetts Amherst)
Hur, Sun Jin (Department of Animal Science and Technology, Chung-Ang University)
Publication Information
Journal of Animal Science and Technology / v.62, no.6, 2020 , pp. 933-947 More about this Journal
Abstract
This study was conducted to develop an effective heparin extraction method by using low-cost and highly effective enzymes from six pig by-products (liver, lung, heart, stomach, small intestine, and large intestine), and analyze their bioavailability. Low-cost and highly effective enzymes (alkaline-AK and papain) and a common enzyme (trypsin) were used for the heparin extraction. The angiotensin I- converting enzyme (ACE) inhibitory activity and the antimicrobial activity of extracted heparin were analyzed to verify their bioavailability. The average amount of heparin extracted per kilogram of pig by-products was 439 mg from the liver, 127 mg from the lung, 398 mg from the heart, 261 mg from the stomach, 197 mg from the small intestine, and 239 mg from the large intestine. Various enzymes were used to extract heparin, and the amount of extracted heparin was similar. Based on 1 g of pig by-product, the enzymes trypsin, papain, and alkaline-AK could extract 1,718 mg, 1,697 mg, and 1,905 mg of heparin, respectively. Heparin extracted from pig by-products showed antihypertensive activity and antimicrobial activity against Staphylococcus aureus at low populations. These results indicated that heparin can be obtained from pig by-products at a low cost.
Keywords
Alkaline-AK; Angiotensin I-converting enzyme (ACE) inhibitory activity; Antimicrobial activity; Heparin extraction; Pig by-products;
Citations & Related Records
Times Cited By KSCI : 4  (Citation Analysis)
연도 인용수 순위
1 Delaney SR, Leger M, Conrad HE. Quantitation of the sulfated disaccharides of heparin by high performance liquid chromatography. Anal Biochem. 1980;106:253-61. https://doi.org/10.1016/0003-2697(80)90145-1   DOI
2 Trehy ML, Reepmeyer JC, Kolinski RE, Westenberger BJ, Buhse LF. Analysis of heparin sodium by SAX/HPLC for contaminants and impurities. J Pharm Biomed Anal. 2009;49:670-3. https://doi.org/10.1016/j.jpba.2008.12.013   DOI
3 Imanari T, Toida T, Koshiishi I, Toyoda H. High-performance liquid chromatographic analysis of glycosaminoglycan-derived oligosaccharides. J Chromatogr A.1996;720:275-93. https://doi.org/10.1016/0021-9673(95)00338-X   DOI
4 Yang B, Chang Y, Weyers AM, Sterner E, Linhardt RJ. Disaccharide analysis of glycosaminoglycan mixtures by ultra-high-performance liquid chromatography-mass spectrometry. J Chromatogr A. 2012;1225:91-8. https://doi.org/10.1016/j.chroma.2011.12.063   DOI
5 Auray-Blais C, Bherer P, Gagnon R, Young SP, Zhang HH, An Y, et al. Efficient analysis of urinary glycosaminoglycans by LC-MS/MS in mucopolysaccharidoses type I, II and VI. Mol Genet Metab. 2011;102:49-56. https://doi.org/10.1016/j.ymgme.2010.09.003   DOI
6 Auray-Blais C, Lavoie P, Zhang H, Gagnon R, Clarke JT, Maranda B, et al. An improved method for glycosaminoglycan analysis by LC-MS/MS of urine samples collected on filter paper. Clinica Chimica Acta. 2012;413:771-8. https://doi.org/10.1016/j.cca.2012.01.012   DOI
7 Rawlings ND, Barrett AJ. Evolutionary families of peptidases. Biochem J. 1993;290:205-18. https://doi.org/10.1042/bj2900205   DOI
8 Howell WH, Holt E. Two new factors in blood coagulation: heparin and pro-antithrombin. Am J Physiol. 1918;47:328-41. https://doi.org/10.1152/ajplegacy.1918.47.3.328   DOI
9 Lever R, Page CP. Novel drug development opportunities for heparin. Nat Rev Drug Discovery. 2002;1:140. https://doi.org/10.1038/nrd724   DOI
10 Sun W, Han J, Li Q, Jiao K. Spectrophotometric and voltammetric studies on the interaction of heparin with crystal violet and its analytical application. S Afr J Chem. 2007;60:42-6.
11 Abbott EC, Gornall AG, Sutherland DJA, Stiefel M, Laidlaw JC. The influence of a heparin-like compound on hypertension, electrolytes and aldosterone in man. Can Med Assoc J. 1966;94:1155-64.
12 Sealey JE, Gerten JN, Ledingham JGG, Laragh JH. Inhibition of renin by heparin. J Clin Endocrinol Metab. 1967;27:699-705. https://doi.org/10.1210/jcem-27-5-699   DOI
13 Susie D, Mandal AK, Jovovic D, Stojanov M, Djordjevic‐Denic G, Kentera D. Antihypertensive action of heparin: role of the renin‐angiotensin aldosterone system and prostaglandins. J Clin Pharmacol. 1993;33:342-7.   DOI
14 Droste JC, Jeraj HA, MacDonald A, Farrington K. Stability and in vitro efficacy of antibiotic-heparin lock solutions potentially useful for treatment of central venous catheter-related sepsis. J Antimicrob Chemother. 2003;51:849-55. https://doi.org/10.1093/jac/dkg179   DOI
15 Petitou M, Casu B, Lindahl U. 1976-1983, a critical period in the history of heparin: the discovery of the antithrombin binding site. Biochimie. 2003;85:83-9. https://doi.org/10.1016/S0300-9084(03)00078-6   DOI
16 Miceli MH, Bernardo SM, Ku TN, Walraven C, Lee SA. In vitro analyses of the effects of heparin and parabens on Candida albicans biofilms and planktonic cells. Antimicrob Agents Chemother. 2012;56:148-53. https://doi.org/10.1128/AAC.05061-11   DOI
17 Arciola CR, Bustanji Y, Conti M, Campoccia D, Baldassarri L, Samorì B, et al. Staphylococcus epidermidis-fibronectin binding and its inhibition by heparin. Biomaterials. 2003;24:3013-9. https://doi.org/10.1016/S0142-9612(03)00133-9   DOI
18 Hanno PM, Fritz R, Wein AJ, Mulholland SG. Heparin as antibacterial agent in rabbit bladder. Urology. 1978;12:411-5. https://doi.org/10.1016/0090-4295(78)90291-1   DOI
19 Choi JP. Animal byproduct(blood) current status & usage. Korean J Food Sci Anim Resour. 2013;2:2-7.
20 Rosett W, Hodges GR. Antimicrobial activity of heparin. J Clin Microbiol. 1980;11:30-4. https://doi.org/10.1128/JCM.11.1.30-34.1980   DOI
21 Charles AF, Scott DA. Studies on heparin I. The preparation of heparin. Int J Biol Chem. 1933;102:425-9.   DOI
22 Charles AF, Scott DA. Studies on heparin II. Heparin in various tissues. Int J Biol Chem. 1933;102:431-5.   DOI
23 Charles AF, Scott DA. Studies on heparin III. The purification of heparin. Int J Biol Chem. 1933;102:437-48.   DOI
24 Freeman L, Posthuma R, Gordon L, Marx W. Determination of tissue heparin. Arch Biochem Biophys. 1957;70:169-77. https://doi.org/10.1016/0003-9861(57)90090-5   DOI
25 Volpi N. Disaccharide analysis and molecular mass determination to microgram level of single sulfated glycosaminoglycan species in mixtures following agarose-gel electrophoresis. Anal Biochem. 1999;273:229-39. https://doi.org/10.1006/abio.1999.4218   DOI
26 Jeon KH. Current production and utilization of animal by-products. Korean J Food Sci Anim Resour. 2013;2:8-16.
27 Yoon SY, Lee DY, Kim OY, Lee SY, Hur SJ. Development of commercially viable method of conjugated linoleic acid synthesis using linoleic acid fraction obtained from pork by-products. Korean J Food Sci Anim Resour. 2018;38:693. https://doi.org/10.5851/kosfa.2018.e6   DOI
28 Lee SY, Yoon SY, Lee DY, Kim OY, Kim HS, Jung EY, et al. Development of batch processing to obtain bioactive materials from pork byproducts. Anim Prod Sci. 2020;60:316-22. https://doi.org/10.1071/AN18600   DOI
29 Tyagi AK, Kumar S, Choudhury PK, Tyagi B, Tyagi N. Conjugated linoleic acid producing potential of lactobacilli isolated from goat (AXB) rumen fluid samples. Asian-Australas J Anim Sci. 2020;33:1233. https://doi.org/10.5713/ajas.19.0080   DOI
30 Lee MS, Kong J. Heparin: physiology, pharmacology, and clinical application. Rev Cardiovasc Med. 2015;16:189-99. https://doi.org/10.3909/ricm0778   DOI
31 Sarwar MI, Hussain MS, Rauf A. Heparin can be isolated and purified from bovine intestine by different techniques. Int J Pharm Sci Invent. 2013;2:21-5.
32 Arumugam M, Shanmugam A. Extraction of heparin and heparin-like substance from marine mesogastropod mollusc Turritella attenuata (Lamarck, 1779). Indian J Exp Biol. 2004;42:529-32.
33 Cushman DW, Cheung HS. Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung. Biochem Pharmacol. 1971;20:1637-48. https://doi.org/10.1016/0006-2952(71)90292-9   DOI